Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathwayMathieu Chocry(Inserm), Hervé Kovacic(Centre National de la Recherche Scientifique)OncotargetOctober 10, 201710.18632/oncotarget.21780Cited by 35SaveCiteExport RISWatch citationsRelated PapersTau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis|Cancers|2021|27